Cargando…
Neratinib is an MST1 inhibitor and restores pancreatic β-cells in diabetes
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895035/ https://www.ncbi.nlm.nih.gov/pubmed/31815004 http://dx.doi.org/10.1038/s41420-019-0232-0 |
_version_ | 1783476506752712704 |
---|---|
author | Ardestani, Amin Tremblay, Matthew S. Shen, Weijun Maedler, Kathrin |
author_facet | Ardestani, Amin Tremblay, Matthew S. Shen, Weijun Maedler, Kathrin |
author_sort | Ardestani, Amin |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6895035 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-68950352019-12-06 Neratinib is an MST1 inhibitor and restores pancreatic β-cells in diabetes Ardestani, Amin Tremblay, Matthew S. Shen, Weijun Maedler, Kathrin Cell Death Discov Comment Nature Publishing Group UK 2019-12-05 /pmc/articles/PMC6895035/ /pubmed/31815004 http://dx.doi.org/10.1038/s41420-019-0232-0 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Comment Ardestani, Amin Tremblay, Matthew S. Shen, Weijun Maedler, Kathrin Neratinib is an MST1 inhibitor and restores pancreatic β-cells in diabetes |
title | Neratinib is an MST1 inhibitor and restores pancreatic β-cells in diabetes |
title_full | Neratinib is an MST1 inhibitor and restores pancreatic β-cells in diabetes |
title_fullStr | Neratinib is an MST1 inhibitor and restores pancreatic β-cells in diabetes |
title_full_unstemmed | Neratinib is an MST1 inhibitor and restores pancreatic β-cells in diabetes |
title_short | Neratinib is an MST1 inhibitor and restores pancreatic β-cells in diabetes |
title_sort | neratinib is an mst1 inhibitor and restores pancreatic β-cells in diabetes |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895035/ https://www.ncbi.nlm.nih.gov/pubmed/31815004 http://dx.doi.org/10.1038/s41420-019-0232-0 |
work_keys_str_mv | AT ardestaniamin neratinibisanmst1inhibitorandrestorespancreaticbcellsindiabetes AT tremblaymatthews neratinibisanmst1inhibitorandrestorespancreaticbcellsindiabetes AT shenweijun neratinibisanmst1inhibitorandrestorespancreaticbcellsindiabetes AT maedlerkathrin neratinibisanmst1inhibitorandrestorespancreaticbcellsindiabetes |